The characterisation of the immune microenvironment in murine pancreatic tumours established from cells displaying different Sema3a statuses suggested profound remodelling of the TME by tumour-derived SEMA3A (figure 6E,F and online supplemental figure S6E,F). This evidence concerns the gene SEMA3A and pancreatic neoplasm.